Effect of thyroid hormone suppression on control of advanced well-differentiated thyroid cancer.

Suppr

超能文献

作者信息

Iñiguez-Ariza Nicole M, Stan Marius N, Bible Keith C

机构信息

Mayo Clinic Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Rochester, MN, USA.

Mayo Clinic Division of Medical Oncology, Rochester, MN, USA.

出版信息

Endocrine. 2018 Jan;59(1):228-229. doi: 10.1007/s12020-017-1464-5. Epub 2017 Nov 1.

DOI:10.1007/s12020-017-1464-5

PMID:29094258

Abstract

摘要

相似文献

Effect of thyroid hormone suppression on control of advanced well-differentiated thyroid cancer.

Endocrine. 2018 Jan;59(1):228-229. doi: 10.1007/s12020-017-1464-5. Epub 2017 Nov 1.

Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative Registry.分化型甲状腺癌患者的促甲状腺激素抑制与疾病进展：来自国家甲状腺癌治疗合作登记处的结果

Thyroid. 1998 Sep;8(9):737-44. doi: 10.1089/thy.1998.8.737.

Serum thyroglobulin levels after thyroxine withdrawal in patients with low risk papillary thyroid carcinoma.低风险甲状腺乳头状癌患者甲状腺素撤药后的血清甲状腺球蛋白水平

Thyroid. 2000 Feb;10(2):165-9. doi: 10.1089/thy.2000.10.165.

Effects of short-term metformin therapy associated with levothyroxine dose decrement on TSH and thyroid hormone levels in patients with thyroid cancer.短期二甲双胍治疗联合左甲状腺素剂量递减对甲状腺癌患者促甲状腺激素和甲状腺激素水平的影响。

Minerva Endocrinol. 2014 Mar;39(1):59-65.

Serum TSH and risk of papillary thyroid cancer in nodular thyroid disease.血清促甲状腺激素与结节性甲状腺疾病中甲状腺乳头状癌的风险。

J Clin Endocrinol Metab. 2012 Apr;97(4):1134-45. doi: 10.1210/jc.2011-2735. Epub 2012 Jan 25.

[Potential risks of the adverse effects of thyrotropin suppression in differentiated thyroid carcinoma].[分化型甲状腺癌促甲状腺素抑制治疗的潜在不良反应风险]

Endocrinol Nutr. 2011 Feb;58(2):75-83. doi: 10.1016/j.endonu.2010.09.007. Epub 2011 Jan 17.

[Hormonal therapy in differentiated carcinoma of the thyroid gland].[甲状腺分化型癌的激素治疗]

Chir Ital. 1994;46(4):56-8.

Effect of UGT1A1, UGT1A3, DIO1 and DIO2 polymorphisms on L-thyroxine doses required for TSH suppression in patients with differentiated thyroid cancer.UGT1A1、UGT1A3、DIO1和DIO2基因多态性对分化型甲状腺癌患者促甲状腺激素抑制所需左甲状腺素剂量的影响。

Br J Clin Pharmacol. 2014 Nov;78(5):1067-75. doi: 10.1111/bcp.12437.

[Rosiglitazone in two patients with thyroglobulin-positive and radioiodine-negative differentiated thyroid cancer: preliminary results].

Med Clin (Barc). 2008 Oct 4;131(11):435. doi: 10.1157/13126222.

Bone mineral density in patients receiving suppressive doses of thyroxine for thyroid carcinoma.接受抑制剂量甲状腺素治疗甲状腺癌患者的骨矿物质密度

N Z Med J. 1993 Oct 27;106(966):443-4.

引用本文的文献

Inhibition of circular RNA_0000285 prevents cell proliferation and induces apoptosis in thyroid cancer by sponging microRNA-654-3p.环状RNA_0000285的抑制通过吸附微小RNA-654-3p来阻止甲状腺癌细胞增殖并诱导其凋亡。

Oncol Lett. 2021 Sep;22(3):673. doi: 10.3892/ol.2021.12934. Epub 2021 Jul 19.

本文引用的文献

2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.2015年美国甲状腺协会成人甲状腺结节和分化型甲状腺癌管理指南：美国甲状腺协会甲状腺结节和分化型甲状腺癌指南工作组

Thyroid. 2016 Jan;26(1):1-133. doi: 10.1089/thy.2015.0020.

Thyroid. 1998 Sep;8(9):737-44. doi: 10.1089/thy.1998.8.737.

Degree of thyrotropin suppression as a prognostic determinant in differentiated thyroid cancer.促甲状腺素抑制程度作为分化型甲状腺癌的预后决定因素

J Clin Endocrinol Metab. 1996 Dec;81(12):4318-23. doi: 10.1210/jcem.81.12.8954034.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验